MGRO logo

MustGrow Biologics Stock Price

Symbol: TSXV:MGROMarket Cap: CA$46.6mCategory: Materials

MGRO Share Price Performance

MGRO Community Fair Values

    Recent MGRO News & Updates

    No updates

    MustGrow Biologics Corp. Key Details

    CA$4.2m

    Revenue

    CA$3.6m

    Cost of Revenue

    CA$557.5k

    Gross Profit

    CA$6.1m

    Other Expenses

    -CA$5.5m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.10
    Gross Margin
    13.34%
    Net Profit Margin
    -131.46%
    Debt/Equity Ratio
    475.4%

    MustGrow Biologics Corp. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About MGRO

    Founded
    2014
    Employees
    n/a
    CEO
    Corey Giasson
    WebsiteView website
    mustgrow.ca

    MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

    Canadian Market Performance

    • 7 Days: 0.9%
    • 3 Months: 11.7%
    • 1 Year: 17.4%
    • Year to Date: 10.1%
    The Consumer Staples sector gained 3.6% while the market remained flat over the last week. As for the longer term, the market has risen 17% in the past 12 months. Earnings are forecast to grow by 12% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading